These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 30614939)

  • 21. Pediatric Eosinophilic Esophagitis Is Associated With Increased Lamina Propria Immunoglobulin G4-Positive Plasma Cells.
    Mohammad N; Avinashi V; Chan E; Vallance BA; Portales-Casamar E; Bush JW
    J Pediatr Gastroenterol Nutr; 2018 Aug; 67(2):204-209. PubMed ID: 29509633
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Celiac disease, eosinophilic esophagitis and gastroesophageal reflux disease, an adult population-based study.
    Ludvigsson JF; Aro P; Walker MM; Vieth M; Agréus L; Talley NJ; Murray JA; Ronkainen J
    Scand J Gastroenterol; 2013 Jul; 48(7):808-14. PubMed ID: 23672638
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Barrett's Esophagus in Eosinophilic Esophagitis in Swiss Eosinophilic Esophagitis Cohort Study (SEECS).
    Scherer R; Schreiner P; Rossel JB; Greuter T; Burri E; Saner C; Schlag C; Safroneeva E; Schoepfer A; Straumann A; Biedermann L;
    Dig Dis; 2023; 41(5):695-707. PubMed ID: 37231862
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical, endoscopic, and histologic findings distinguish eosinophilic esophagitis from gastroesophageal reflux disease.
    Dellon ES; Gibbs WB; Fritchie KJ; Rubinas TC; Wilson LA; Woosley JT; Shaheen NJ
    Clin Gastroenterol Hepatol; 2009 Dec; 7(12):1305-13; quiz 1261. PubMed ID: 19733260
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased number of regulatory T cells in esophageal tissue of patients with eosinophilic esophagitis in comparison to gastro esophageal reflux disease and control groups.
    Mousavinasab F; Babaie D; Nilipour Y; Mansouri M; Imanzadeh F; Dara N; Rohani P; Khatami K; Sayyari A; Khoddami M; Kazemiaghdam M; Mesdaghi M
    Allergol Immunopathol (Madr); 2019; 47(5):431-436. PubMed ID: 31178311
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical features distinguish eosinophilic and reflux-induced esophagitis.
    Mulder DJ; Hurlbut DJ; Noble AJ; Justinich CJ
    J Pediatr Gastroenterol Nutr; 2013 Mar; 56(3):263-70. PubMed ID: 23085895
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnostic utility of major basic protein, eotaxin-3, and leukotriene enzyme staining in eosinophilic esophagitis.
    Dellon ES; Chen X; Miller CR; Woosley JT; Shaheen NJ
    Am J Gastroenterol; 2012 Oct; 107(10):1503-11. PubMed ID: 22777338
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High-resolution manometry in patients with eosinophilic esophagitis under topical steroid therapy-a prospective observational study (HIMEOS-study).
    Nennstiel S; Bajbouj M; Becker V; Slotta-Huspenina J; Wagenpfeil S; Schmid RM; Schlag C
    Neurogastroenterol Motil; 2016 Apr; 28(4):599-607. PubMed ID: 26891170
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Eosinophilic esophagitis: Pathophysiology, diagnosis, and management.
    Vinit C; Dieme A; Courbage S; Dehaine C; Dufeu CM; Jacquemot S; Lajus M; Montigny L; Payen E; Yang DD; Dupont C
    Arch Pediatr; 2019 Apr; 26(3):182-190. PubMed ID: 30827775
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cost-effectiveness model of endoscopic biopsy for eosinophilic esophagitis in patients with refractory GERD.
    Miller SM; Goldstein JL; Gerson LB
    Am J Gastroenterol; 2011 Aug; 106(8):1439-45. PubMed ID: 21448144
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular diagnosis of eosinophilic esophagitis by gene expression profiling.
    Wen T; Stucke EM; Grotjan TM; Kemme KA; Abonia JP; Putnam PE; Franciosi JP; Garza JM; Kaul A; King EC; Collins MH; Kushner JP; Rothenberg ME
    Gastroenterology; 2013 Dec; 145(6):1289-99. PubMed ID: 23978633
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of eosinophilic esophagitis in patients with gastroesophageal reflux symptoms: A cross-sectional study from a tertiary care hospital in North India.
    Baruah B; Kumar T; Das P; Thakur B; Sreenivas V; Ahuja V; Gupta SD; Makharia GK
    Indian J Gastroenterol; 2017 Sep; 36(5):353-360. PubMed ID: 29022245
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of eotaxin-3 biomarker in patients with eosinophilic oesophagitis, proton pump inhibitor-responsive oesophageal eosinophilia and gastro-oesophageal reflux disease.
    Moawad FJ; Wells JM; Johnson RL; Reinhardt BJ; Maydonovitch CL; Baker TP
    Aliment Pharmacol Ther; 2015 Jul; 42(2):231-8. PubMed ID: 26011446
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pattern of esophageal eosinophilic infiltration in patients with achalasia and response to Heller myotomy and Dor fundoplication.
    Cools-Lartigue J; Chang SY; Mckendy K; Mayrand S; Marcus V; Fried GM; Ferri LE
    Dis Esophagus; 2013; 26(8):766-75. PubMed ID: 22891632
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Manometric features of eosinophilic esophagitis in esophageal pressure topography.
    Roman S; Hirano I; Kwiatek MA; Gonsalves N; Chen J; Kahrilas PJ; Pandolfino JE
    Neurogastroenterol Motil; 2011 Mar; 23(3):208-14, e111. PubMed ID: 21091849
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oesophageal intrasquamous IgG4 deposits: an adjunctive marker to distinguish eosinophilic oesophagitis from reflux oesophagitis.
    Zukerberg L; Mahadevan K; Selig M; Deshpande V
    Histopathology; 2016 Jun; 68(7):968-76. PubMed ID: 26466342
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multimodality evaluation of patients with gastroesophageal reflux disease symptoms who have failed empiric proton pump inhibitor therapy.
    Galindo G; Vassalle J; Marcus SN; Triadafilopoulos G
    Dis Esophagus; 2013 Jul; 26(5):443-50. PubMed ID: 22862422
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Eosinophilic esophagitis in patients with typical gastroesophageal reflux disease symptoms refractory to proton pump inhibitor.
    Sá CC; Kishi HS; Silva-Werneck AL; Moraes-Filho JP; Eisig JN; Barbuti RC; Hashimoto CL; Navarro-Rodriguez T
    Clinics (Sao Paulo); 2011; 66(4):557-61. PubMed ID: 21655746
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Filaggrin and Periostin Expression Is Altered in Eosinophilic Esophagitis and Normalized With Treatment.
    Politi E; Angelakopoulou A; Grapsa D; Zande M; Stefanaki K; Panagiotou I; Roma E; Syrigou E
    J Pediatr Gastroenterol Nutr; 2017 Jul; 65(1):47-52. PubMed ID: 28644349
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Markers of antigen presentation and activation on eosinophils and T cells in the esophageal tissue of patients with eosinophilic esophagitis.
    Le-Carlson M; Seki S; Abarbanel D; Quiros A; Cox K; Nadeau KC
    J Pediatr Gastroenterol Nutr; 2013 Mar; 56(3):257-62. PubMed ID: 23059644
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.